Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Epilepsy

  Free Subscription


Articles published in Rev Neurol

Retrieve available abstracts of 58 articles:
HTML format



Single Articles


    November 2024
  1. IGLESIAS-RODRIGUEZ M, Navarro-Abia V, Barbadillo-Mariscal B, Gil-Calderon FJ, et al
    [Characteristics of patients with drug-resistant epilepsy in a tertiary hospital].
    Rev Neurol. 2024;79:273-277.
    PubMed     Abstract available


    October 2024
  2. EBRAT-MANCILLA E, Sanchez-Aparicio A, Perez de Vargas-Martinez A, Marin-Serrano ME, et al
    [Epilepsy in Angelman syndrome and the most common electroencephalographic findings].
    Rev Neurol. 2024;79:223-228.
    PubMed     Abstract available


  3. RESENDIZ-APARICIO JC, Lopez-Vargas Y, Vargas-Ramirez G, Rogel-Cuevas J, et al
    [Etiology of epilepsy in Mexico: results from the national multi-centre register].
    Rev Neurol. 2024;79:199-206.
    PubMed     Abstract available


    September 2024
  4. MOYA-LOPEZ S, Ruiz-Colodrero A, Sainz-Garcia J, Farina-Jara V, et al
    [Epilepsy and inborn errors of metabolism].
    Rev Neurol. 2024;79:129-135.
    PubMed     Abstract available


  5. ARENAS-CABRERA C, Cabezudo-Garcia P, Calvo-Medina R, Galeano-Bilbao B, et al
    [Advances and guidance in the treatment of drug-resistant epilepsy: a review by the Andalusian Epilepsy Society of the new drugs cenobamate, fenfluramine and cannabidiol].
    Rev Neurol. 2024;79:161-173.
    PubMed     Abstract available


  6. MORTE-COSCOLIN P, Gomez-Sanchez C, Lopez-Pison J, Farina-Jara MV, et al
    [Withdrawal and reintroduction of pharmacological treatment of epilepsy in paediatric patients. Our experience].
    Rev Neurol. 2024;79:147-154.
    PubMed     Abstract available


    August 2024
  7. FERNANDEZ-CABRERA A, Santamaria-Montero P, Garcia-de Soto J, Ortegon-Aguilar E, et al
    Epilepsy and musical perception. A perspective involving 14 patients.
    Rev Neurol. 2024;79:107-113.
    PubMed     Abstract available


    July 2024
  8. PENA-SALAZAR C, Kazah N, Carrillo B, Diaz C, et al
    Neurologic comorbidity in psychiatric inpatients: evidence from neurologic consultations in a Spanish center.
    Rev Neurol. 2024;79:11-20.
    PubMed     Abstract available


    June 2024
  9. ANTONIO-CRUZ A, Prieto-Corona B, Yanez-Tellez MG, Amaya-Hernandez A, et al
    [Neuropsychological profile of Mexican paediatric patients with pharmacoresistant focal epilepsy].
    Rev Neurol. 2024;78:343-354.
    PubMed     Abstract available


  10. JARAMILLO-JIMENEZ E, Hoyos-Rubio JD, Jimenez-Jaramillo ME, Torres-Bustamante M, et al
    Memory and language risk assessment with Wada test in patients candidates for epilepsy surgery.
    Rev Neurol. 2024;78:295-305.
    PubMed     Abstract available


    May 2024
  11. LOPEZ-MAZA S, Abraira L, Bellido-Castillo E, Lallana S, et al
    [Risk of epilepsy after a first epileptic seizure with unknown etiology in elderly patients].
    Rev Neurol. 2024;78:277-283.
    PubMed     Abstract available


  12. SAIZ-DIAZ RA, Bellido-Cuellar S, Gonzalez de la Aleja J
    [Normal variants with an epileptiform appearance in electroencephalograms. A literature review and clinical implications].
    Rev Neurol. 2024;78:253-263.
    PubMed     Abstract available


    April 2024
  13. POZA-ALDEA JJ
    [The importance of adherence to treatment in control of epilepsy].
    Rev Neurol. 2024;78:237.
    PubMed    


    February 2024
  14. RIVERA D, Santos D, Carmant L, Garcia HH, et al
    [Diagnosis of neurocysticercosis in patients with epilepsy living in the south-western Dominican Republic].
    Rev Neurol. 2024;78:109-116.
    PubMed     Abstract available


  15. IVAROLA P, Gonzalez B, Tedeschini I, Cordoba F, et al
    [Acute symptomatic epileptic seizures. A clinical-electroencephalographic etiological description and prognosis of an oncopediatric series].
    Rev Neurol. 2024;78:93-99.
    PubMed     Abstract available


  16. BELLIDO-CASTILLO E, Lopez-Sala A, Aparicio J, Cuadras D, et al
    Verbal episodic memory in children undergoing temporal lobe epilepsy surgery: a one-year follow-up study.
    Rev Neurol. 2024;78:61-71.
    PubMed     Abstract available


    January 2024
  17. RESENDIZ-APARICIO JC, Ruiz-Garcia M, Castro-Martinez E
    [A multicentre epilepsy registry in Mexico].
    Rev Neurol. 2024;78:9-15.
    PubMed     Abstract available


    December 2023
  18. PEREZ-NAVARRO VM, Canovas-Iniesta M, Palazon-Cabanes B, Navarro-Lozano M, et al
    [Epilepsy and inequality: demographic description and analysis of the difficulty in accessing advanced resources in a population in a small health area].
    Rev Neurol. 2023;77:259-265.
    PubMed     Abstract available


    November 2023
  19. HERNANDEZ-PRIETO A, Garrido-Martin M, Gomez-Martin H, Pablos-Lopez A, et al
    [Neonatal seizures and progression to epilepsy in a tertiary hospital].
    Rev Neurol. 2023;77:249-252.
    PubMed     Abstract available


  20. PUERTAS-PORRINO N, Fonseca-Hernandez E, Quintana-Luque M, Meler-Amella P, et al
    [EPICAP: educational intervention using instructional clips in patients with epilepsy. A randomised clinical trial].
    Rev Neurol. 2023;77:215-222.
    PubMed     Abstract available


    October 2023
  21. ORDONO-SAIZ MV, Pua-Torrejon RC, Justel-Rodriguez M, Arias-Vivas E, et al
    Cerebral and cerebellar pseudoatrophy associated with valproic acid. Report of three pediatric cases.
    Rev Neurol. 2023;77:197-201.
    PubMed     Abstract available


    September 2023
  22. ORTIZ-ORTIGOSA A, Calvo-Medina R, Ruiz-Garcia C, Vera-Medialdea R, et al
    [KIF1A gene-associated neurological disease: the correlation between genotype and phenotype].
    Rev Neurol. 2023;77:141-145.
    PubMed     Abstract available


    August 2023
  23. FERNANDEZ-CABRERA A, Lopez-Gonzalez FJ, Garcia-de Soto J, Pardellas-Santiago E, et al
    [The sign of the cross: a very rare automatism in temporal lobe epilepsy. Two case reports].
    Rev Neurol. 2023;77:105-108.
    PubMed     Abstract available


  24. TREJO-GABRIEL-GALAN JM, Cubo-Delgado E
    [Telephone assistance for neurological diseases: a systematic review].
    Rev Neurol. 2023;77:67-73.
    PubMed     Abstract available


    July 2023
  25. ORTIZ-DE LA ROSA JS, Ramon-Gomez JL, Martinez-Cordoba N, Lince-Rivera I, et al
    SARS-CoV-2 vaccination in paediatric patients with epilepsy: experience of a tertiary center in Colombia.
    Rev Neurol. 2023;77:13-18.
    PubMed     Abstract available


    June 2023
  26. VILLAGRAN-SANCHO D, Luque-Ambrosiani AC, Mayorga-Moron C, Gomez-Fernandez FJ, et al
    [Cryptogenic new-onset super-refractory status epilepticus following SARS-CoV-2 vaccination. A case report].
    Rev Neurol. 2023;76:399-402.
    PubMed     Abstract available


    May 2023
  27. PLANS-GALVAN O, Daniel X, Rosich S, Blazquez-Alcaide V, et al
    [Use of isoflurane as treatment for super-refractory status epilepticus].
    Rev Neurol. 2023;76:309-312.
    PubMed     Abstract available


    April 2023
  28. MORENO-MAYORGA B, Velez-Botero H, Fandino-Franky J, Perez-Almanza N, et al
    [Quality of life in people with epilepsy: beyond seizures].
    Rev Neurol. 2023;76:257-264.
    PubMed     Abstract available


  29. LORENZO-RUIZ M, Novo-Ponte S, Iglesias-Escalera G, Cazorla-Calleja R, et al
    [Angelman syndrome in adulthood].
    Rev Neurol. 2023;76:217-226.
    PubMed     Abstract available


    March 2023
  30. SOUSA E, Pinto M, Ferreira M, Monteiro C, et al
    Neurocognitive and psychological comorbidities in patients with self-limited centrotemporal spike epilepsy. A case-control study.
    Rev Neurol. 2023;76:153-158.
    PubMed     Abstract available


    February 2023
  31. PAREDES-ARAGON E, Ruiz-Garcia R, Burneo JG
    [Depression in patients with epilepsy. Pathophysiological and clinical concepts and therapeutic strategies].
    Rev Neurol. 2023;76:137-146.
    PubMed     Abstract available


  32. SALINAS-SALVADOR B, Moreno-Sanchez A, Carmen-Marcen G, Molina-Hernanz D, et al
    ['Wait and see' in paediatric epilepsy. Our experience].
    Rev Neurol. 2023;76:83-89.
    PubMed     Abstract available


    January 2023
  33. DA SILVA CARDOSO J, Curto C, Manuel-Vieira P, Ashworth J, et al
    Primary headache with onset in childhood and adolescence: natural history and prognostic factors in a Portuguese population.
    Rev Neurol. 2023;76:9-14.
    PubMed     Abstract available


    December 2022
  34. PASTOR J, Vega-Zelaya L, Torres CV, Navas-Garcia M, et al
    [Towards a positive physiological definition of the deep brain nuclei in humans].
    Rev Neurol. 2022;75:369-376.
    PubMed     Abstract available


  35. LOPEZ-ANGUITA S, Gutierrez-Ruano B, Munoz-Gonzalez A, Valenzuela-Rojas FJ, et al
    [Epilepsy in cancer patients: primary prevention and the importance of high-risk patient screening].
    Rev Neurol. 2022;75:349-356.
    PubMed     Abstract available


    November 2022
  36. JUIZ-FERNANDEZ A, Chavarria-Miranda A, Prieto-Gonzalez A, Rodriguez-Osorio X, et al
    [No fear of anything: epilepsy, psychiatric comorbidity and surgery. A clinical case report].
    Rev Neurol. 2022;75:319-321.
    PubMed     Abstract available


  37. SERRANO-TABARES C, Trujillo-Gomez J, Morales-Gil RM, Aguilar-Perez Y, et al
    Tolerance and response to ketogenic therapy in neonates and infants younger than 4 months. Case series in a hospital center in Medellin, Colombia.
    Rev Neurol. 2022;75:305-310.
    PubMed     Abstract available


  38. NAVA-CEDENO DJ, Alonso-Cerezo MC, Sanz-Garcia A, Vega-Zelaya L, et al
    [Association between single nucleotide genetic polymorphisms in ABC transporter genes with drug-resistant epilepsy in the Spanish population].
    Rev Neurol. 2022;75:251-259.
    PubMed     Abstract available


    October 2022
  39. SOTO-INSUGA V, Gonzalez-Alguacil E, Garcia-Penas JJ
    [Paediatric status epilepticus].
    Rev Neurol. 2022;75:225-238.
    PubMed     Abstract available


    September 2022
  40. RUBIO-NAZABAL E, Alvarez-Perez P, Cores-Bartolome C, Lema-Facal T, et al
    [Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy].
    Rev Neurol. 2022;75:159-163.
    PubMed     Abstract available


    July 2022
  41. SANCHEZ-ZAPATA P, Zapata-Berruecos JF, Pelaez-Sanchez RG
    [Structural changes to the brain in drug-resistant juvenile myoclonic epilepsy].
    Rev Neurol. 2022;75:23-30.
    PubMed     Abstract available


  42. ARTEAGA-RODRIGUEZ C, Menine-Kubis M, Teixeira-Arteaga CB, Hernandez-Fustes OJ, et al
    Clinical characteristics of patients with epilepsy attending primary health care.
    Rev Neurol. 2022;75:7-12.
    PubMed     Abstract available


    June 2022
  43. ANAYA-GONZALEZ JL, Lopez-Munoz F, Carmona-Alvarez Builla E, Miniet-Castillo AE, et al
    [Correlation between clinical and tomographic variables in patients with neurocysticercosis. A study in a cohort of patients in Sierra Norte, Ecuador, between 2019 and 2020].
    Rev Neurol. 2022;74:383-391.
    PubMed     Abstract available


    May 2022
  44. MOSCOL G, Espino PH, Mayor LC, Burneo JG, et al
    [Epilepsy with catamenial pattern].
    Rev Neurol. 2022;74:303-311.
    PubMed     Abstract available


    April 2022
  45. CATALAN-AGUILAR J, Lozano-Garcia A, Gonzalez-Bono E, Villanueva V, et al
    Academic and employment insertion as a factor related to quality of life in patients with drug-resistant temporal lobe epilepsy.
    Rev Neurol. 2022;74:219-227.
    PubMed     Abstract available


    March 2022
  46. NOGUEIRA M, Melo C, Grangeia A, Magalhaes T, et al
    PURA syndrome in a child with severe developmental delay: a challenging diagnosis.
    Rev Neurol. 2022;74:170-173.
    PubMed     Abstract available


    December 2021
  47. TOLEDANO R, Gil-Nagel A
    [Treatment of epilepsy with perampanel: conversion from add-on therapy to monotherapy].
    Rev Neurol. 2021;73.
    PubMed     Abstract available


  48. SANABRIA-SANCHINEL AA, Escobar-Pineda ES, Oliveros I, Perdomo-Mendizabal AL, et al
    [Telemedicine and epilepsy: healthcare experience of a national reference center during the COVID-19 pandemic].
    Rev Neurol. 2021;73:390-393.
    PubMed     Abstract available


    October 2021
  49. CANO-LOPEZ I, Vazquez-Costa JF, Gutierrez A, Villanueva V, et al
    [Cognitive reserve as a modulating factor in the impact of surgery on visual memory and naming in temporal lobe epilepsy patients].
    Rev Neurol. 2021;73:267-274.
    PubMed     Abstract available


  50. FERNANDEZ-ALONSO C, Gonzalez-Martinez F, Alonso-Aviles R, Linan-Lopez M, et al
    [On the treatment of epileptic seizures in patients with epilepsy in hospital emergency departments].
    Rev Neurol. 2021;73:258-259.
    PubMed    


  51. NAVARRO-PEREZ MP, Viloria-Alebesque A

    Rev Neurol. 2021;73:259-260.
    PubMed    


    September 2021
  52. GARCIA-PENAS JJ, Gil Nagel-Rein A, Sanchez-Carpintero R, Villanueva-Haba V, et al
    Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
    Rev Neurol. 2021;73.
    PubMed     Abstract available


  53. CANTARIN-EXTREMERA V, Bernardino-Cuesta B, Martin-Villaescusa C, Melero-Llorente J, et al
    [Tuberous sclerosis complex: analysis of areas of involvement, treatment progress and translation to routine clinical practice in a cohort of paediatric patients].
    Rev Neurol. 2021;73:141-150.
    PubMed     Abstract available


    July 2021
  54. MARTINEZ-PIAS E, Castineira-Mourenza JA, Prieto-Gonzalez AJ, Rodriguez-Osorio X, et al
    [Temporal pole encephalocele, a surgical treatable cause of drug-resistant epilepsy].
    Rev Neurol. 2021;73:77-79.
    PubMed     Abstract available


  55. CARDENAL-MUNOZ E, Nabbout R, Boronat S, Lara-Herguedas J, et al
    Impact of COVID-19 on Spanish patients with Dravet syndrome and their caregivers: consequences of lockdown.
    Rev Neurol. 2021;73:57-65.
    PubMed     Abstract available


    June 2021
  56. NAVARRO-PEREZ MP, Viloria-Alebesque A, Garces-Anton E, Marin-Gracia M, et al
    [Emergency department management of epileptic seizures in patients with epilepsy].
    Rev Neurol. 2021;72:419-425.
    PubMed     Abstract available


    April 2021
  57. VILLANUEVA V, Carreno-Martinez M, Gil Nagel-Rein A, Lopez-Gonzalez FJ, et al
    New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol.
    Rev Neurol. 2021;72.
    PubMed     Abstract available


  58. HERNANDEZ-RUBIO L, Asensio-Asensio M, Tortosa-Conesa D, Alfaro-Saez A, et al
    [Alzemon: a prospective follow-up study of eslicarbazepine acetate monotherapy in patients with newly diagnosed epilepsy].
    Rev Neurol. 2021;72:263-268.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.